We are live on
!
Find out more
Alnylam Pharmaceuticals
ALNY
ALNY
248 hedge funds and large institutions have $4.11B invested in Alnylam Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 109 increasing their positions, 62 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
104% more call options, than puts
Call options by funds: $68.7M | Put options by funds: $33.7M
76% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 62
2% less funds holding
Funds holding: 254 → 248 (-6)
7% less capital invested
Capital invested by funds: $4.42B → $4.11B (-$307M)
11% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 37
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Holders
248
Holders Change
-6
Holders Change %
-2.36%
% of All Funds
6.62%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.21%
New
33
Increased
109
Reduced
62
Closed
37
Calls
$68.7M
Puts
$33.7M
Net Calls
+$35M
Net Calls Change
+$29.7M
Top Buyers
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$86M |
| 2 |
Royal London Asset Management
United Kingdom
|
-$66.6M |
| 3 |
VAM
Visium Asset Management
New York
|
-$49.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$46M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$22.2M |
